The tyrosine kinase receptor c-Met has been identified as an essential factor responsible for the functional CSC phenotype and for sustaining the undifferentiated/mesenchymal phenotype as well as a significant factor for the initialization of tumor growth under in vivo conditions [21]. The gene discussed is MET; the disease is neoplasm.